Financhill
Sell
45

SBSI Quote, Financials, Valuation and Earnings

Last price:
$29.49
Seasonality move :
3.64%
Day range:
$28.98 - $29.47
52-week range:
$25.30 - $38.00
Dividend yield:
4.93%
P/E ratio:
10.04x
P/S ratio:
3.44x
P/B ratio:
1.09x
Volume:
125.1K
Avg. volume:
96.7K
1-year change:
7.11%
Market cap:
$888M
Revenue:
$257.9M
EPS (TTM):
$2.91

Earnings Data

Next earnings date for SBSI
Apr 25
2025
Most recent earnings per share
$0.71
Missed by $0.01
(Jan 29/2025)
Consensus Estimate
$0.72
(Jan 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SBSI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/25/2025 Q1 $67.4M -- -- $0.67 --
01/29/2025 Q4 $68.1M $67.1M $0.71 $0.72 -$0.01
10/24/2024 Q3 $68.4M $63.2M $0.68 $0.73 -$0.05
07/25/2024 Q2 $64.8M $64.8M $0.81 $0.64 $0.17
04/25/2024 Q1 $67.7M $62.7M $0.71 $0.68 $0.03
01/26/2024 Q4 $64.8M $58M $0.57 $0.67 -$0.10
10/26/2023 Q3 -- -- $0.60 $0.76 -$0.16
07/25/2023 Q2 -- -- $0.81 $0.69 $0.12
04/25/2023 Q1 -- -- $0.83 $0.79 $0.04
01/27/2023 Q4 -- -- $0.87 $0.85 $0.02
10/25/2022 Q3 -- -- $0.84 $0.87 -$0.03
07/25/2022 Q2 -- -- $0.79 $0.76 $0.04
04/26/2022 Q1 -- -- $0.77 -- --
01/28/2022 Q4 -- -- $0.88 -- --
10/26/2021 Q3 -- -- $0.90 -- --
07/23/2021 Q2 -- -- $0.65 -- --
04/23/2021 Q1 -- -- $1.04 -- --
01/27/2021 Q4 -- -- $0.89 -- --
10/23/2020 Q3 -- -- $0.82 -- --
07/22/2020 Q2 -- -- $0.65 -- --
05/05/2020 Q1 -- -- $0.12 -- --
01/31/2020 Q4 -- -- $0.51 -- --
10/25/2019 Q3 -- -- $0.58 -- --
07/26/2019 Q2 -- -- $0.55 -- --
04/26/2019 Q1 -- -- $0.56 -- --
02/01/2019 Q4 -- -- $0.50 -- --
10/26/2018 Q3 -- -- $0.58 -- --
07/27/2018 Q2 -- -- $0.57 -- --
05/01/2018 Q1 -- -- $0.46 -- --
02/06/2018 Q4 -- -- $0.32 -- --
10/27/2017 Q3 -- -- $0.49 -- --
07/28/2017 Q2 -- -- $0.49 -- --
04/28/2017 Q1 -- -- $0.51 -- --
01/27/2017 Q4 -- -- $0.42 -- --
10/28/2016 Q3 -- -- $0.48 -- --
07/29/2016 Q2 -- -- $0.42 -- --
04/29/2016 Q1 -- -- $0.50 -- --
01/29/2016 Q4 -- -- $0.43 -- --
10/30/2015 Q3 -- -- $0.43 -- --
07/23/2015 Q2 -- -- $0.41 -- --
04/30/2015 Q1 -- -- $0.34 -- --

Southside Bancshares Earnings Questions

  • How Much did Southside Bancshares Generate in Revenue Last Quarter?

    Southside Bancshares reported $67.1M worth of top line sales in its most recent quarter.

  • Did Southside Bancshares Beat Earnings Last Quarter?

    Southside Bancshares announced earnings per share of $0.71 which represents a miss of analyst forecast a $0.72 per share.

  • Is Southside Bancshares Profitable?

    Southside Bancshares reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Southside Bancshares EPS Next Year?

    Southside Bancshares's earnings are forecast to decrease from $2.91 per share to $2.97 per share next year representing a decrease of -2.66%.

  • When is Southside Bancshares's Earnings Date?

    Southside Bancshares's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
52
RGC alert for Mar 19

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 5.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock